Literature DB >> 34331270

Novel Interventional Techniques for Chronic Pain with Minimally Invasive Arthrodesis of the Sacroiliac Joint: (INSITE, iFuse, Tricor, Rialto, and others).

Alan D Kaye1,2, Amber N Edinoff3, Logan Scoon4, Sean Youn5, Kyle J Farrell6, Aaron J Kaye7, Rutvij J Shah8, Elyse M Cornett8, Azem A Chami8, Bruce M Dixon8, Michael A Alvarado8, Omar Viswanath5,6,9, Ivan Urits8,10, Aaron K Calodney8,11.   

Abstract

Acute and chronic pain are public health issues that clinicians have been battling for years. Opioid medications have been a treatment option for both chronic and acute pain; however, they can cause unwanted complications and are a major contributor to our present opioid epidemic. The sacroiliac (SI) joint is a common cause of both acute and chronic low back pain. It affects about 15-25% of patients with axial low back pain, and up to 40% of patients with ongoing pain following lumbar fusion. Recent advances in the treatment of SI joint pain have led to the development of a wide variety of SI joint fusion devices. These fusion devices seek to stabilize the joints themselves in order that they become immobile and, in theory, can no longer be a source for pain. This is a minimally invasive procedure aimed to address chronic pain without subjecting patients to lengthy surgery or medications, including opioids with the potential for addiction and abuse. Minimally invasive SI fusion can be performed by a lateral approach (i.e., iFuse, Tricor) or posterior approach (i.e., CornerLoc, LinQ, Rialto). The posterior approach requires the patient to be in the prone position but allows for less disruption of muscles with entry. More data are necessary to determine which fusion system may be best for a particular patient. SI fusion devices are a promising way of treating chronic lower back pain related to the SI joint. This narrative review will discuss various types of SI fusion devices, and their potential use in terms of their safety and efficacy.
© 2021. The Author(s).

Entities:  

Keywords:  CornerLoc; Low back pain; Minimal invasive surgery; Rialto; SI Joint pain; Tricor; iFuse

Year:  2021        PMID: 34331270     DOI: 10.1007/s40744-021-00350-8

Source DB:  PubMed          Journal:  Rheumatol Ther        ISSN: 2198-6576


  3 in total

1.  Obstructed spinopelvic fixation in the setting of a triangular titanium sacroiliac fusion implant: a case description.

Authors:  Joseph L Laratta; James D Lin; Jamal N Shillingford; Nathan E Hardy; Hemant Reddy; Ronald A Lehman
Journal:  J Spine Surg       Date:  2017-12

Review 2.  Acute and chronic pain: where we are and where we have to go.

Authors:  M Allegri; M R Clark; J De Andrés; T S Jensen
Journal:  Minerva Anestesiol       Date:  2011-11-18       Impact factor: 3.051

3.  [Clinical Trial to Test the iFuse Implant System® in Patients with Sacroiliac Joint Syndrome: One Year Results].

Authors:  R Bornemann; R Pflugmacher; M Webler; E M W Koch; J Dengler; D C Wirtz; S P Frey
Journal:  Z Orthop Unfall       Date:  2016-07-07       Impact factor: 0.923

  3 in total
  3 in total

Review 1.  Minimally Invasive and Conservative Interventions for the Treatment of Sacroiliac Joint Pain: A Review of Recent Literature.

Authors:  Mayank Aranke; Grace McCrudy; Kelsey Rooney; Kunaal Patel; Christopher A Lee; Jamal Hasoon; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

2.  Salvage of Failed Lateral Sacroiliac Joint Fusion with a Novel Posterior Sacroiliac Fusion Device: Diagnostic Approach, Surgical Technique, and Multicenter Case Series.

Authors:  Dawood Sayed; Nasir Khatri; Adam Rupp; Christopher Bovinet; Nomen Azeem; Sean Li; Youssef Josephson; Jason Pope
Journal:  J Pain Res       Date:  2022-05-12       Impact factor: 2.832

Review 3.  Advances in Pain Medicine: a Review of New Technologies.

Authors:  Natalie Strand; Maloney J; Vinicius Tieppo Francio; Murphy M; Michal Turkiewicz; Antonios El Helou; Maita M; Covington S; Singh N; Peck J; Wie C
Journal:  Curr Pain Headache Rep       Date:  2022-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.